A5043353145- Schizophrenia research and treatment
- Functional Brain Connectivity Studies
- Cannabis and Cannabinoid Research
- Mental Health Research Topics
- Neurotransmitter Receptor Influence on Behavior
- Mental Health and Psychiatry
- Bipolar Disorder and Treatment
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Psychosomatic Disorders and Their Treatments
- Neural and Behavioral Psychology Studies
- Substance Abuse Treatment and Outcomes
- Pain Management and Placebo Effect
- Digital Mental Health Interventions
- Pain Mechanisms and Treatments
- Child and Adolescent Psychosocial and Emotional Development
- Treatment of Major Depression
- Musculoskeletal pain and rehabilitation
- Advanced Neuroimaging Techniques and Applications
- Attention Deficit Hyperactivity Disorder
- Psychopathy, Forensic Psychiatry, Sexual Offending
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Tryptophan and brain disorders
- Mental Health Treatment and Access
- Sleep and Wakefulness Research
- Smoking Behavior and Cessation
Université de Montréal
2016-2025
Institut Universitaire en Santé Mentale de Québec
2016-2025
Hôpital Louis-H Lafontaine
2015-2024
Douglas Mental Health University Institute
2017-2024
University of Lausanne
2023
Centres Intégré Universitaires de Santé et de Services Sociaux
2022
Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal
2017-2020
Institut Philippe Pinel de Montréal
2019-2020
Centre Hospitalier de l’Université de Montréal
2014-2018
University of Vermont
2017
Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic, antiemetic and anti-inflammatory properties. However, up to this point, comprehensive literature review the effects CBD humans lacking. The aim present systematic examine randomized crossover studies that administered healthy controls clinical patients. A search was performed electronic databases PubMed EMBASE using key word "cannabidiol". Both...
Abstract Although fibromyalgia (FM) is associated with a deficit in inhibitory conditioned pain modulation (CPM), the discriminative power of CPM procedures unknown. Moreover, high intersubject heterogeneity responses FM raises possibility that sizeable subgroup these patients may experience facilitation during CPM, but phenomenon has not been explicitly studied. To address issues, 96 and 71 healthy controls were recruited. Thermal stimuli used to measure thresholds. Pain inhibition was...
The gold-standard cognitive-behavioral therapy (CBT) for psychosis offers at best modest effects. With advances in technology, virtual reality (VR) therapies auditory verbal hallucinations (AVH), such as AVATAR (AT) and VR-assisted (VRT), are amid a new wave of relational approaches that may heighten Prior trials have shown greater effects these on AVH up to 24-week follow-up. However, no trial has compared them recommended active treatment with 1-year We performed pilot randomized...
On pathophysiologic grounds, fibromyalgia (FM) is characterized by a deficit in diffuse noxious inhibitory controls (DNIC), but the role of depressive symptoms on these mechanisms has not been investigated. We hypothesized that pain inhibition would be more pronounced FM patients with (FM+D), relative to without such (FM-D).Fifty-two women diagnosed (American College Rheumatology criteria) and 10 healthy participated this study. Thermal stimuli were used measure thresholds DNIC efficacy...
Article AbstractBackground: Given the complex relationships between fibromyalgia and major depressive disorder (MDD), it has been suggested that is a "masked" MDD. In experimental settings, associated with lowered pain thresholds (hyperalgesia) deficient inhibition. Similarly, recently proposed proneness of patients MDD to develop chronic results from deficit in This cross-sectional study measured experimentally induced perception inhibition fibromyalgia. Method: Participants were 29...